Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1991
The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological methodB Pakkenberg, A Møller, H J Gundersen, et al.European Journal of Clinical Pharmacology|August 1, 1980
Bromocriptine concentration in saliva plasma after long-term treatment of patients with Parkinson's diseaseM L Friis, T Johnsen, N E Larsen, et al.European Journal of Clinical Pharmacology|May 21, 1979
Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's diseaseM L Friis, U Grøn, N E Larsen, et al.Neurotoxicology and Teratology|April 7, 1999
MPTP-induced Parkinsonism in minipigs: A behavioral, biochemical, and histological studyM Mikkelsen, A Møller, L H Jensen, et al.Journal of Neuroscience Methods|February 1, 1990
An efficient method for estimating the total number of neurons in rat brain cortexL Korbo, B Pakkenberg, O Ladefoged, et al.The New England Journal of Medicine|May 30, 1985
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)R S Burns, P A LeWitt, M H Ebert, et al.Acta Neurologica Scandinavica|June 1, 1989
Tetrahydrobiopterin and Parkinson's diseaseI C Dissing, F Güttler, H Pakkenberg, et al.Neuroscience|November 9, 2007
The effect of age and gender on the volume and size distribution of neocortical neuronsA K Stark, M H Toft, H Pakkenberg, et al.Acta Neurologica Scandinavica|May 1, 1976
Parkinson's disease treated with Sinemet or Madopar. A controlled multicenter trialH Pakkenberg, E Birket-Smith, E Dupont, et al.Journal of Neurology|December 2, 1975
Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trialU K Rinne, E Birket-Smith, E Dupont, et al.Pageof 6